CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Open Label Extension In Cancer Patients [Phase 2]
Summary
Open-label extension study in cancer patients (Phase 2) completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Neoplasms, Bone Metastases | Phase 2 | Status: COMPLETED | Results posted: 2021-02-02